Serum aminotransferase levels in patients with severe obstructive sleep apnea Source: Annual Congress 2012 - Metabolic and cardiovascular consequences of OSA I Year: 2012
S100B protein: A useful marker in obstructive sleep apnea syndrome Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Elevated serum homocysteine levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 566s Year: 2004
The impact of obstructive sleep apnoea hypopnoea syndrome (OSAHS) on serum creatine phosphokinase (CK) levels in children Source: Annual Congress 2010 - Adenotonsillectomy and paediatric sleep medicine Year: 2010
Creatine phosphokinase elevation is highly predictive of obstructive sleep apnoea syndrome (OSAS) in patients with suspected sleep disordered breathing Source: Eur Respir J 2005; 26: Suppl. 49, 114s Year: 2005
C-reactive protein levels can predict obstructive sleep apnea / hypopnea syndrome? Source: Eur Respir J 2004; 24: Suppl. 48, 118s Year: 2004
C-reactive protein levels in obstructive sleep apnea syndrome Source: Eur Respir J 2005; 26: Suppl. 49, 356s Year: 2005
Elevated c-reactive protein (CRP) levels in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 332s Year: 2004
Serum vitamin D, physical activity and the obstructive sleep apnea syndrome Source: Annual Congress 2012 - Sleep apnoea: clinical topics Year: 2012
Serum fibrinogen in patients with obstructive sleep apnea Source: Virtual Congress 2020 – Consequences for obstructive sleep apnoea and potential modalities for early identification Year: 2020
Elevated c-reactive protein in patients with obstructive sleep apnea hypopnea syndrome (OSAH) Source: Annual Congress 2007 - Systemic effects of obstructive sleep apnoea Year: 2007
Investigation on serum adiponectin levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 445s Year: 2004
High sensitivity C-reactive protein (CRP) in patients with obstructive sleep apnoea syndrome Source: Eur Respir J 2003; 22: Suppl. 45, 566s Year: 2003
Plasma levels of TNF in obstructive sleep apnea syndrome (OSA) before and after surgical intervention Source: Annual Congress 2012 - Clinical predictors of OSA, adherence to CPAP and psychology Year: 2012
Urinary biomarkers for obstructive sleep apnea syndrome: Lipocalin type prostaglandin-D synthase and F2-isoprostane Source: International Congress 2018 – Sleep-disordered breathing: biomarkers and genetics and the role of hypoxia, insomnia, movement disorders and sleep quality Year: 2018
The relationship between serum cytokine levels with obesity and obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 113s Year: 2004
Serum resistin level in pediatric obstructive sleep apnea Source: Annual Congress 2008 - Paediatric respiratory epidemiology I: primary ciliary dyskinesia, sleep-disordered breathing, exercise-induced symptoms and rare diseases Year: 2008
Hepcidin: the new marker for determining nocturnal hypoxia in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009
Plasma vascular endothelial growth factor levels in patients with obstructive sleep apnea hypopnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004
Plasma antioxidant factors in persons with different stages of obstructive sleep apnea syndrome Source: Eur Respir J 2004; 24: Suppl. 48, 564s Year: 2004